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Additional file 2 Variation in national policy content 
   
 
 
National Guidelines for CPT 
Country  Malawi  Malawi  Uganda Zambia 
Year of 
publication 
2002 2005 2005 2007 
HIV 
exposed
None From 6 weeks until HIV ruled out. Infants 
HIV 
infected 
None CPT regardless of clinical signs or 
symptoms, age or CD4 count.  
Should not be discontinued. 
<1yr- CPT regardless of symptoms and of 
CD4%  
>1yr CPT if in stage 2, 3 or 4 or if CD4% 
<25%. 
Should not be discontinued. 
Children  2-5 year olds who are 
HIV infected with TB 
for the duration of the 
TB treatment. If 
patients wish to 
continue after this then 
they had to request 
CPT from local 
hospital.  
CPT for all 
HIV infected 
children 
regardless of 
whether they 
are on ART.  
 
Should not be 
discontinued.  
CPT for all HIV infected 
children regardless of 
whether they are on ART.  
 
Ideally for life. 
Discontinuation to be 
decided upon on an 
individual basis by the 
care provider.  
1-5 year olds CPT if in stage 2, 3 or 4 or if 
CD4% <25%. 
 
<5 do not discontinue CTP.  
 
>5 consider stopping CPT if good clinical and 
immune recovery, CD4 response, and secure 
supply of drugs.  
 
 
Adults All HIV infected TB 
patients for the duration 
of their treatment. If 
patients wish to 
continue after this then 
they had to request 
CPT from their local 
hospital. 
CPT for adults 
in stages 2-4 or 
with CD4 
count <500 
cells/mm3.  
 
Should not be 
discontinued.  
 
CPT to be given to all HIV 
infected adults.  
 
Ideally for life. 
Discontinuation to be 
decided upon on an 
individual basis by the 
care provider. 
CPT for all in WHO stages 2,3 and 4 regardless 
of CD4 count. 
 
CD4 <350 cells/mm3. regardless of clinical 
stage.  
 
Discontinue CPT after CD4 >350 cells/mm3.  
for >6 months 
Monitor 3 monthly. 
 
 
